AFLAC Incorporated  

(Public, NYSE:AFL)   Watch this stock  
Find more results for AFL
+0.16 (0.22%)
Jul 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 73.17 - 73.50
52 week 51.41 - 74.14
Open 73.47
Vol / Avg. 0.00/1.99M
Mkt cap 30.49B
P/E 12.09
Div/yield 0.41/2.23
EPS 6.08
Shares 413.99M
Beta 1.41
Inst. own 69%
Sep 12, 2016
Aflac Inc Corporate Tokyo Financial Analyst Briefing Add to calendar
Jul 29, 2016
Q2 2016 Aflac Inc Earnings Call - 9:00AM EDT - Add to calendar
Jul 28, 2016
Q2 2016 Aflac Inc Earnings Release Add to calendar
May 25, 2016
Aflac Inc Financial Analysts Briefing
May 2, 2016
Aflac Inc Annual Shareholders Meeting
Apr 27, 2016
Q1 2016 Aflac Inc Earnings Call
Apr 26, 2016
Q1 2016 Aflac Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 13.38% 12.05%
Operating margin 21.63% 19.74%
EBITD margin - 25.78%
Return on average assets 2.38% 2.13%
Return on average equity 15.54% 14.05%
Employees 9,915 -
CDP Score - 97 C


United States - Map
+1-706-3233431 (Phone)
+1-706-3246330 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Aflac Incorporated is a business holding company. The Company engaged in is supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac's insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells supplemental insurance products, including products designed to protect individuals from depletion of assets, such as accident, cancer, critical illness/care, hospital intensive care, hospital indemnity, fixed-benefit dental, and vision care plans and loss-of-income products.

Officers and directors

Daniel P. Amos Chairman of the Board, Chief Executive Officer of the Company and Aflac
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kriss Cloninger III President, Director
Age: 68
Bio & Compensation  - Reuters
Frederick J. Crawford Chief Financial Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Paul S. Amos II President of Aflac, Director
Age: 40
Bio & Compensation  - Reuters
Charles Ditmars Lake II President of Aflac International
Age: 54
Bio & Compensation  - Reuters
Teresa L. White President of Aflac U.S.
Age: 49
Bio & Compensation  - Reuters
Hiroshi Yamauchi President and Chief Operating Officer of Aflac Japan
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kenneth S. Janke Jr. Executive Vice President - Corporate Finance and Development, Treasurer
Age: 57
Bio & Compensation  - Reuters
Audrey Boone Tillman Esq. Executive Vice President, General Counsel, Aflac Incorporated and Aflac
Age: 51
Bio & Compensation  - Reuters
Koji Ariyoshi Executive Vice President, Director - Marketing and Sales of Aflac Japan
Age: 62
Bio & Compensation  - Reuters